Latest AI and machine learning research in prostate cancer for healthcare professionals.
BACKGROUND: Prostate cancer with regional lymph node involvement but no distant metastasis (N1M0) has heterogeneous prognosis. This study aimed to develop and validate an interpretable machine learning model for predicting cancer-specific survival (CSS). METHODS: Data from 18,287 N1M0 patients (2000-2022) in the SEER database were divided into training (n = 4780), internal testing (n = 1193), and ...
BACKGROUND: Accurate delineation of the prostate and surrounding organs-at-risk (OARs) is essential for HDR prostate brachytherapy. Manual contouring on post-catheter CT images is time-consuming and prone to variability due to artifacts and anatomical deformation from the implanted brachytherapy catheters. PURPOSE: To develop and validate a 3D deep learning autosegmentation model for prostate and ...
BACKGROUND: Tumor-Specific Peptides (TSPs) and Tumor-associated Overexpressed Proteins (TOPs) are promising biomarkers for cancer diagnosis and monito...
PURPOSE: To develop and externally validate a simplified apparent diffusion coefficient (ADC)-based MRI radiomics model for differentiating benign and...
Multimodal artificial intelligence (AI) is reshaping prostate cancer imaging by moving beyond MRI-only algorithms toward models that integrate multipa...
Purpose.In high-dose-rate (HDR) prostate brachytherapy procedures, needle placement solely relies on physician experience. We investigated the feasibi...
OBJECTIVES: Accurate pre-biopsy or preoperative diagnosis and risk stratification of prostate cancer remain challenging. This study aimed to develop a...
Prostate cancer (PCa) is the most commonly diagnosed noncutaneous malignancy in men and a leading cause of cancer-related death worldwide. Its clinica...
OBJECTIVE: To investigate risk factors for urinary incontinence (UI) after robot-assisted laparoscopic radical prostatectomy (RARP) using interpretabl...
BACKGROUND AND OBJECTIVE: Accurate risk stratification in localized prostate cancer is essential for guiding treatment decisions. Conventional Nationa...
BACKGROUND: Avoidable prostate biopsies remain a persistent weakness of prostate specific antigen (PSA)- and imaging-led prostate cancer (PCa) diagnos...
BACKGROUND: The Phoenix definition is widely used to define biochemical recurrence (BCR) after radiation therapy for prostate cancer; however, a defin...
INTRODUCTION: Psoriatic arthritis is a chronic inflammatory disease that can affect the axial skeleton as well as the joints and enthesis. Following t...
OBJECTIVE: To evaluate the diagnostic accuracy and patient acceptability of fAI-BRO (Fibromyalgia AI-Based Rheumatology Observer), a multimodal artifi...
OBJECTIVES: This study aimed to develop a clinical-radiomics model based on T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) to improve...
Active surveillance (AS) is widely used for men with low-risk and selected favorable intermediate-risk prostate cancer, but pathways remain heterogene...
BACKGROUND: Diffuse gliomas remain among the most surgically challenging tumors, characterized by their infiltrative nature, proximity to eloquent bra...
Prostate‑specific antigen (PSA) screening reduces prostate cancer (PCa) mortality but is limited by overdiagnosis and poor specificity for clinically ...
BACKGROUND AND OBJECTIVE: Metastatic hormone-sensitive prostate cancer (mHSPC) exhibits heterogeneous progression patterns, with early progression to ...